1.40
price down icon0.71%   -0.01
pre-market  Vorhandelsmarkt:  1.40  
loading
Schlusskurs vom Vortag:
$1.41
Offen:
$1.42
24-Stunden-Volumen:
373.69K
Relative Volume:
0.31
Marktkapitalisierung:
$74.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-51.47M
KGV:
-1.40
EPS:
-1
Netto-Cashflow:
$-47.50M
1W Leistung:
-11.39%
1M Leistung:
-2.78%
6M Leistung:
+40.48%
1J Leistung:
-14.11%
1-Tages-Spanne:
Value
$1.38
$1.47
1-Wochen-Bereich:
Value
$1.38
$1.54
52-Wochen-Spanne:
Value
$0.81
$1.84

Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile

Name
Firmenname
Pmv Pharmaceuticals Inc
Name
Telefon
(609) 642-6670
Name
Adresse
400 ALEXANDER PARK DRIVE, PRINCETON
Name
Mitarbeiter
47
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
PMVP's Discussions on Twitter

Vergleichen Sie PMVP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PMVP
Pmv Pharmaceuticals Inc
1.40 74.72M 0 -51.47M -47.50M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-08 Hochstufung Oppenheimer Perform → Outperform
2024-05-13 Eingeleitet Craig Hallum Buy
2024-04-12 Eingeleitet Jefferies Buy
2023-12-27 Eingeleitet Ladenburg Thalmann Buy
2022-03-02 Hochstufung Oppenheimer Perform → Outperform
2021-09-22 Hochstufung Goldman Neutral → Buy
2021-08-19 Eingeleitet Oppenheimer Perform
2021-08-02 Eingeleitet Guggenheim Buy
2021-07-29 Eingeleitet H.C. Wainwright Buy
2020-10-20 Eingeleitet BofA Securities Buy
2020-10-20 Eingeleitet Cowen Outperform
2020-10-20 Eingeleitet Evercore ISI Outperform
2020-10-20 Eingeleitet Goldman Neutral
Alle ansehen

Pmv Pharmaceuticals Inc Aktie (PMVP) Neueste Nachrichten

pulisher
01:26 AM

Applying chart zones and confluence areas to PMV Pharmaceuticals Inc.Weekly Stock Summary & Long-Term Growth Stock Strategies - newser.com

01:26 AM
pulisher
Nov 03, 2025

Published on: 2025-11-03 22:20:58 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is PMV Pharmaceuticals Inc. stock poised for growthWeekly Gains Summary & Weekly Watchlist for Consistent Profits - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Can PMV Pharmaceuticals Inc. stock deliver surprise earnings beatDollar Strength & Community Supported Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is PMV Pharmaceuticals Inc. stock resilient to inflationEntry Point & Daily Oversold Bounce Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

PMV Pharmaceuticals Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView

Nov 03, 2025
pulisher
Nov 03, 2025

Real time social sentiment graph for PMV Pharmaceuticals Inc.Breakout Watch & Daily Chart Pattern Signal Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How rising interest rates impact PMV Pharmaceuticals Inc. stockShare Buyback & AI Powered Market Trend Analysis - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will PMV Pharmaceuticals Inc. bounce back from current support2025 Market Outlook & Proven Capital Preservation Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using fundamentals and technicals on PMV Pharmaceuticals Inc.Weekly Investment Report & Free Growth Oriented Trading Recommendations - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

PMV Pharmaceuticals Insider Stock Sellers Must Be Relieved As Market Cap Falls To US$75m - simplywall.st

Nov 03, 2025
pulisher
Nov 03, 2025

Using AI based signals to follow PMV Pharmaceuticals Inc.Volume Spike & Comprehensive Market Scan Insights - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Tangible book value per share of PMV Pharmaceuticals, Inc. – BOATS:PMVP - TradingView

Nov 02, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 07:20:04 - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 06:42:35 - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Will PMV Pharmaceuticals Inc. stock benefit from automationMarket Activity Report & Free Fast Gain Swing Trade Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Sees Significant Growth in Short Interest - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 11:39:40 - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is PMV Pharmaceuticals Inc. building a consolidation baseWeekly Market Outlook & Entry Point Confirmation Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

What drives PMV Pharmaceuticals Inc stock priceTrade Execution Strategies & Small Budget Trading Plans - earlytimes.in

Nov 01, 2025
pulisher
Oct 31, 2025

Orbimed Advisors LLC Reduces Stake in PMV Pharmaceuticals Inc - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

How institutional buying supports PMV Pharmaceuticals Inc. stock2025 Big Picture & Accurate Entry and Exit Point Alerts - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

PMV Pharmaceuticals (PMVP) Expected to Announce Earnings on Thursday - MarketBeat

Oct 30, 2025
pulisher
Oct 29, 2025

[Form 4] PMV Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan

Oct 29, 2025
pulisher
Oct 28, 2025

PMV Pharmaceuticals (NASDAQ:PMVP) Major Shareholder Orbimed Advisors Llc Sells 1,000,000 Shares - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Is PMV Pharmaceuticals Inc. stock positioned well for digital economyStock Surge & Accurate Intraday Trade Tips - fcp.pa.gov.br

Oct 28, 2025

Finanzdaten der Pmv Pharmaceuticals Inc-Aktie (PMVP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Pmv Pharmaceuticals Inc-Aktie (PMVP) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
ORBIMED ADVISORS LLC
10% Owner
Oct 23 '25
Sale
1.52
1,000,000
1,520,000
4,975,291
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):